Several clinical trials are
testing cell replacement therapies to treat spinal cord injuries.
Not exact matches
Information on the clinical
testing of ViaCyte's implantable
cell replacement therapies can be found at Clinicaltrials.gov.
The VC - 01 product candidate is the first embryonic stem
cell - derived islet
replacement therapy to reach clinical
testing and is currently being evaluated in patients with T1D who have minimal to no insulin - producing beta
cell function.